From Laurus Labs, Lupin to Biocon— Pharma stocks rise up to 3% despite Trump’s 200% tariff threat

Pharma stocks showed resilience on July 9, with several companies like Laurus Labs and Lupin rising up to 3%. US President Donald Trump has reiterated that he would impose very high tariffs on pharmaceutical imports to the US.